子宫内膜乳头状浆液性腺癌与透明细胞癌临床分析

王春延 高燕 胡元晶

王春延, 高燕, 胡元晶. 子宫内膜乳头状浆液性腺癌与透明细胞癌临床分析[J]. 中国肿瘤临床, 2012, 39(23): 1912-1915. doi: 10.3969/j.issn.1000-8179.2012.23.011
引用本文: 王春延, 高燕, 胡元晶. 子宫内膜乳头状浆液性腺癌与透明细胞癌临床分析[J]. 中国肿瘤临床, 2012, 39(23): 1912-1915. doi: 10.3969/j.issn.1000-8179.2012.23.011
Chun-yan WANG, Yan GAO, Yuan-jing HU. Clinical Analysis of Uterine Papillary Serous Carcinoma and Uterine Clear Cell Carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(23): 1912-1915. doi: 10.3969/j.issn.1000-8179.2012.23.011
Citation: Chun-yan WANG, Yan GAO, Yuan-jing HU. Clinical Analysis of Uterine Papillary Serous Carcinoma and Uterine Clear Cell Carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(23): 1912-1915. doi: 10.3969/j.issn.1000-8179.2012.23.011

子宫内膜乳头状浆液性腺癌与透明细胞癌临床分析

doi: 10.3969/j.issn.1000-8179.2012.23.011
详细信息
    通讯作者:

    胡元晶   tdjhyj@hotmail.com

Clinical Analysis of Uterine Papillary Serous Carcinoma and Uterine Clear Cell Carcinoma

More Information
  • 摘要:   目的  分析子宫内膜乳头状浆液性腺癌(UPSC)与透明细胞癌(UCCC)的临床特点及预后。   方法  回顾性分析天津市中心妇产科医院2004年4月至2012年7月收治的41例UPSC与19例UCCC临床资料。   结果   UPSC完全手术分期24例, 早期(仅Ⅰ期)9例, 晚期(Ⅲ、Ⅳ期)15例。UCCC完全手术分期10例, 早期(仅Ⅰ期)6例, 晚期(Ⅲ、Ⅳ期)4例。单因素分析显示: 脉管浸润、腹水/腹腔冲洗液细胞学阳性及淋巴结转移者总生存期(OS)较短; 脉管浸润、肌层浸润、腹水/腹腔冲洗液细胞学阳性者无病生存期(DFS)较短。多因素Cox回归分析显示: 淋巴结转移、腹水/腹腔冲洗液细胞学阳性者的患者OS较短; 脉管浸润、腹水/腹腔冲洗液细胞学阳性者的患者DFS较短。   结论  UPSC确诊时多为晚期, 预后差。治疗强调全面手术分期, 脉管浸润、肌层浸润、腹水/腹腔冲洗液及淋巴结转移与预后相关。

     

  • 图  1  脉管浸润患者生存曲线

    Figure  1.  Overall survival curves in patients with vascular invasion

    图  2  腹水/腹腔冲洗液细胞学阳性患者生存曲线

    Figure  2.  Overall survival curves in patients with positive ascites/peritoneal washing cytology

    图  3  脉管浸润患者DFS

    Figure  3.  Disease-free survival curves in patients with vascular invasion

    图  4  腹水/腹腔冲洗液细胞学阳性患者DFS

    Figure  4.  Disease-free survival curves in patients with positive ascites/peritoneal washing cytology

    表  1  手术病理分期 例

    Table  1.   Pathological staging during surgery

    表  2  术后病理结果 例

    Table  2.   Pathological results after surgery

  • [1] Einstein MH, Frimer M, Kuo DY, et al. Phase Ⅱ trial of adjuvant pelvic radiation "sandwiched "between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma[J]. Gynecol Oncol, 2012, 124(1): 21-25. doi: 10.1016/j.ygyno.2011.10.007
    [2] 任玉兰, 王华英, 沈磊, 等. 子宫内膜浆液性乳头状癌33例临床分析[J]. 中华妇产科杂志, 2006, 41(12): 817-821. doi: 10.3760/j.issn:0529-567X.2006.12.007
    [3] Mendivil A, Schuler KM, Gehrig PA, et al. Non-Endometrioid Adenocarcinoma of the Uterine Corpus: A Review of Selected Histological Subtypes[J]. Cancer Control, 2009, 16(1): 46-52. doi: 10.1177/107327480901600107
    [4] Viswanathan AN, Macklin EA, Berkowitz R, et al. The importance of chemotherapy and radiation in uterine papillary serous carcinoma[J]. Gynecol Oncol, 2011, 123(3): 542-547. doi: 10.1016/j.ygyno.2011.09.005
    [5] Busmanis I, Ho TH, Tan SB, et al. p53 and bcl-2 Expression in Invasive and Pre-invasive Uterine Papillary Serous Carcinoma and Atrophic Endometrium[J]. Ann Acad Med Singapore, 2005, 34(7): 421-425.
    [6] Gupta D, Gunter MJ, Yang K, et al. Performance of Serum CA125 as a Prognostic Biomarker in Patients With Uterine Papillary Serous Carcinoma[J]. Int J Gynecol Cancer, 2011, 21(3): 529-534. doi: 10.1097/IGC.0b013e31821091b5
    [7] Skaznik-Wikiel ME, Ueda SM, Frasure HE, et al. Abnormal Cervical Cytology in the Diagnosis of Uterine Papillary Serous Carcinoma: Earlier Detection of a Poor Prognostic Cancer Subtype[J]? Acta Cytol, 2011, 55(3): 255-260. doi: 10.1159/000324052
    [8] Rauh-Hain JA, Growdon WB, Schorge JO, et al. Prognostic determinants in patients with stage ⅢC and Ⅳ uterine papillary serous carcinoma[J]. Gynecol Oncol, 2010, 119(2): 299-304. doi: 10.1016/j.ygyno.2010.07.010
    [9] Fader AN, Drake RD, O'Malley DM, et al. Platinum/Taxane-based Chemotherapy With or Without Radiation Therapy Favorably Impacts Survival outcomes in stage I uterine papillary serous carcinoma[J]. Cancer, 2009, 115(10): 2119-2127. doi: 10.1002/cncr.24247
  • 加载中
图(4) / 表(2)
计量
  • 文章访问数:  103
  • HTML全文浏览量:  20
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-09-03
  • 修回日期:  2012-11-06

目录

    /

    返回文章
    返回